Windward Bio seeks Nasdaq listing to fund respiratory, skin disease drug trials
In
Investing.comBy Investing.com10/24/2026, 12:08:40 AM
EXECUTIVE SUMMARY
Windward Bio seeks Nasdaq listing to fund respiratory, skin disease drug trials....
Key Takeaways
- Windward Bio seeks Nasdaq listing to fund respiratory, skin disease drug trials.
Read Complete Original Article
Published originally on Investing.com
Related News
finance4 minutes ago
Form 4 Provectus Biopharmaceuticals Inc: Edward Pershing (Director, 10% Owner, CEO) For: 23 October - Investing.com Australia
Form 4 Provectus Biopharmaceuticals Inc: Edward Pershing (Director, 10% Owner, CEO) For: 23 October Investing.com Australia
finance4 minutes ago
Form 4 The Greenbrier Companies, Inc: William Glenn (SVP & President, Europe) For: 21 October - Investing.com Australia
Form 4 The Greenbrier Companies, Inc: William Glenn (SVP & President, Europe) For: 21 October Investing.com Australia
finance6 minutes ago
Form 4 Silvia, Inc: Renae Terese Cormier (Former Chief Financial Officer) For: 21 October - Investing.com Australia
Form 4 Silvia, Inc: Renae Terese Cormier (Former Chief Financial Officer) For: 21 October Investing.com Australia
finance7 minutes ago
Form 4 Firy Inc: Todd A. Valli (Chief Accounting Officer) For: 23 October - Investing.com Australia
Form 4 Firy Inc: Todd A. Valli (Chief Accounting Officer) For: 23 October Investing.com Australia
Multikhabar App
All Information In One Place
Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!